Acute Myeloid Leukemia, Refractory Clinical Trials in Milwaukee, Wisconsin
2 recruitingMilwaukee, Wisconsin
Showing 1–2 of 2 trials
Recruiting
Phase 1
Venetoclax to Augment Epigenetic Modification and Chemotherapy
Acute Myeloid Leukemia, in RelapseAcute Myeloid Leukemia, Refractory
Medical College of Wisconsin40 enrolled1 locationNCT05317403
Recruiting
Phase 1
Study of Iadademstat and Gilteritinib in Patients With R/R AML With FMS-like Tyrosine Kinase Mutation (FLT3 Mut+)
Acute Myeloid Leukemia, in RelapseAcute Myeloid Leukemia, Refractory
Oryzon Genomics S.A.50 enrolled13 locationsNCT05546580